Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

ClinicalTrials.gov ID: NCT06742281

Public ClinicalTrials.gov record NCT06742281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 8:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA (CVXGA50) Intranasal COVID-19 Vaccine in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently approved COVID-19 vaccine in the prevention of symptomatic, RT-PCR-confirmed SARS-CoV-2 infection. The trial will enroll up to 434 healthy participants.

Study identification

NCT ID
NCT06742281
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CyanVac LLC
Industry
Enrollment
432 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2024
Primary completion
Jun 14, 2026
Completion
Jun 14, 2026
Last update posted
Jul 9, 2026

2024 – 2026

United States locations

U.S. sites
55
U.S. states
22
U.S. cities
47
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207
Velocity Clinical Research, Phoenix Phoenix Arizona 85006
Velocity Clinical Research, Chula Vista Chula Vista California 91911
Velocity Clinical Research, San Diego La Mesa California 91942
Imax Clinical Trials La Palma California 90623
Artemis Institute for Clinical Research Riverside California 92503
Clinical Innovations Inc. dba CITrials Riverside California 92506
Avacare Sacramento California 95864
Collaborative Neuroscience Research, LLC Torrance California 90504
Velocity Clinical Research, Washington DC Washington D.C. District of Columbia 20016
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009
Homestead Associates in Research, Inc Homestead Florida 33033
Biscayne Clinical Research North Miami Beach Florida 33169
Headlands Research Orlando Orlando Florida 32819
Best Choice Medical and Research Service Pembroke Pines Florida 33024
Forcare Clinical Research Tampa Florida 33613
Guardian Angel Research Center Tampa Florida 33614
Lifeline Primary Care/Avacare Lilburn Georgia 30047
Velocity Clinical Research, Savannah Savannah Georgia 31406
Clinical Research Atlanta Stockbridge Georgia 30281
Velocity Clinical Research, Boise Meridian Idaho 83642
Velocity Clinical Research, Sioux City Sioux City Iowa 51106
Velocity Clinical Research, Covington Covington Louisiana 70433
Velocity Clinical Research, Lafayette Lafayette Louisiana 70508
Velocity Clinical Research, New Orleans New Orleans Louisiana 70119
CBH Health Gaithersburg Maryland 20877
Advanced Primary and Geriatric Care/Avacare Rockville Maryland 20850
Velocity Clinical Research, Rockville Rockville Maryland 20854
DM Clinical Research Southfield Michigan 48076
Velocity Clinical Research - Norfolk Norfolk Nebraska 68701
Quality Clinical Research, Inc Omaha Nebraska 68114
Velocity Clinical Research, Omaha Omaha Nebraska 68134
DM Clinical Research Jersey City New Jersey 07306
Velocity Clinical Research, Binghamton Binghamton New York 13905
Rochester Clinical Research Rochester New York 14609
Trial Management Associates, LLC Wilmington North Carolina 28403
Velocity Clinical Research, Cleveland Beachwood Ohio 44122
Velocity Clinical Research, Mt. Auburn Cincinnati Ohio 45219
Velocity Clinical Research, Springdale Cincinnati Ohio 45246
Tekton Research, LLC Yukon Oklahoma 73099
DM Clinical Research Philadelphia Pennsylvania 19107
Velocity Clinical Research, Anderson Anderson South Carolina 29621
Velocity Clinical Research Gaffney Gaffney South Carolina 29340
Avacare Austin Texas 78705
Tekton Research, LLC Austin Texas 78745
Velocity Clinical Research, Austin Austin Texas 78759
Pan American Clinical Research, LLC Brownsville Texas 78520
Avacare Fort Worth Texas 76135
DM Clinical Research Houston Texas 77065
DM Clinical Research Houston Texas 77081
Avacare San Angelo Texas 76904
Tekton Research, LLC San Antonio Texas 78229
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088
Clinical Research Partners LLC Richmond Virginia 23226
Velocity Clinical Research, Suffolk Suffolk Virginia 23435

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06742281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06742281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →